| Literature DB >> 34026439 |
Runqi Zhu1,2, Tianqun Lang1,2,3, Wenlu Yan1,2, Xiao Zhu1,2, Xin Huang1,2, Qi Yin1,2,3, Yaping Li1,2,3,4.
Abstract
Gut microbiota have close interactions with the host. It can affect cancer progression and the outcomes of cancer therapy, including chemotherapy, immunotherapy, and radiotherapy. Therefore, approaches toward the modulation of gut microbiota will enhance cancer prevention and treatment. Modern drug delivery systems (DDS) are emerging as rational and promising tools for microbiota intervention. These delivery systems have compensated for the obstacles associated with traditional treatments. In this review, the essential roles of gut microbiota in carcinogenesis, cancer progression, and various cancer therapies are first introduced. Next, advances in DDS that are aimed at enhancing the efficacy of cancer therapy by modulating or engineering gut microbiota are highlighted. Finally, the challenges and opportunities associated with the application of DDS targeting gut microbiota for cancer prevention and treatment are briefly discussed.Entities:
Keywords: cancer therapy; carcinogenesis; drug delivery system; gut microbiota; modulation
Mesh:
Year: 2021 PMID: 34026439 PMCID: PMC8132165 DOI: 10.1002/advs.202003542
Source DB: PubMed Journal: Adv Sci (Weinh) ISSN: 2198-3844 Impact factor: 16.806